TrialThe Journal of clinical endocrinology and metabolism2017

Glucagon Decreases IGF-1 Bioactivity in Humans, Independently of Insulin, by Modulating Its Binding Proteins.

Zeinab Sarem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.